-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Satsuma Pharmaceuticals, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q1 2023.
- Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $1.09M, a 11.8% decline year-over-year.
- Satsuma Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense for the twelve months ending March 31, 2023 was $5.56M, a 8.28% increase year-over-year.
- Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $5.71M, a 6.36% increase from 2021.
- Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $5.36M, a 33.5% increase from 2020.
- Satsuma Pharmaceuticals, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $4.02M, a 438% increase from 2019.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)